Clinicians should maintain a high index of suspicion for parathyroid carcinoma when evaluating patients with primary hyperparathyroidism, especially if there are palpable masses or atypical imaging findings alongside elevated parathyroid hormone (PTH) and hypercalcemia levels. This evidence concerns the gene PTH and primary hyperparathyroidism.